Suvretta Capital Management’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $58.1M | Sell |
|
|||||
|
2025
Q2 | $56M | Buy |
|
|||||
|
2025
Q1 | $56.7M | Hold |
|
|||||
|
2024
Q4 | $41.6M | Buy |
|
|||||
|
2024
Q3 | $48.8M | Buy |
|
|||||
|
2024
Q2 | $49.4M | Hold |
|
|||||
|
2024
Q1 | $49.7M | Buy |
|
|||||
|
2023
Q4 | $32.9M | Buy |
|
|||||
|
2023
Q3 | $23.3M | Buy |
|
|||||
|
2023
Q2 | $18.3M | Buy |
|
|||||
|
2023
Q1 | $15.6M | Buy |
|
|||||
|
2022
Q4 | $7.25M | Sell |
|
|||||
|
2022
Q3 | $24.8M | Sell |
|
|||||
|
2022
Q2 | $19M | Buy |
|
|||||
|
2022
Q1 | $25.7M | Hold |
|
|||||
|
2021
Q4 | $23.1M | Buy |
|
|||||
|
2021
Q3 | $26.9M | Buy |
|
|||||
|
2021
Q2 | $28.5M | Buy |
|
|||||
|
2021
Q1 | $24.7M | Buy |
|
|||||
|
2020
Q4 | $5.87M | Hold |
|
|||||
|
2020
Q3 | $3.89M | Buy |
|
|||||
|
2020
Q2 | $2.99M | Buy |
|
|||||
|
2020
Q1 | $874K | Buy |
|